chr7-16308599-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM5
The NM_001101426.4(CRPPA):āc.713C>Gā(p.Thr238Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,609,408 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T238I) has been classified as Uncertain significance.
Frequency
Consequence
NM_001101426.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CRPPA | NM_001101426.4 | c.713C>G | p.Thr238Ser | missense_variant | 4/10 | ENST00000407010.7 | |
CRPPA | NM_001101417.4 | c.563C>G | p.Thr188Ser | missense_variant | 3/9 | ||
CRPPA | NM_001368197.1 | c.685-7133C>G | intron_variant | ||||
CRPPA | NR_160656.1 | n.901-30373C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CRPPA | ENST00000407010.7 | c.713C>G | p.Thr238Ser | missense_variant | 4/10 | 5 | NM_001101426.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000368 AC: 9AN: 244596Hom.: 0 AF XY: 0.0000529 AC XY: 7AN XY: 132368
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1457268Hom.: 1 Cov.: 29 AF XY: 0.0000138 AC XY: 10AN XY: 724654
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152140Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74308
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2U Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Aug 29, 2022 | - - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 24, 2022 | This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 238 of the ISPD protein (p.Thr238Ser). This variant is present in population databases (rs397515409, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of ISPD-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 1680772). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant disrupts the p.Thr238 amino acid residue in ISPD. Other variant(s) that disrupt this residue have been observed in individuals with ISPD-related conditions (PMID: 23217329, 31909476), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at